Impact of Food and Drug Administration Approval of Vismodegib on Prevalence of Orbital Exenteration as a Necessary Surgical Treatment for Locally Advanced Periocular Basal Cell Carcinoma.

Impact of Food and Drug Administration Approval of Vismodegib on Prevalence of Orbital Exenteration as a Necessary Surgical Treatment for Locally Advanced Periocular Basal Cell Carcinoma. Ophthalmic Plast Reconstr Surg. 2019 Jul/Aug; 35(4):350-353.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Anilides
Carcinoma, Basal Cell
Drug Approval
Eyelid Neoplasms
Female
Follow-Up Studies
Humans
Male
Middle Aged
Neoplasm Staging
Orbit Evisceration
Pyridines
Retrospective Studies
Treatment Outcome
United States
United States Food and Drug Administration

authors with profiles

BONNIE S GLISSON
BITA ESMAELI
RENATA FERRAROTTO
PRIYADHARSINI NAGARAJAN
FAYE M JOHNSON